Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization

Diana V. Do, Susan B. Bressler, Sandra D. Cassard, Emily W. Gower, Homayoun Tabandeh, Joan L. Jefferys, Neil M. Bressler

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint Dive into the research topics of 'Ranibizumab for macular telangiectasia type 2 in the absence of subretinal neovascularization'. Together they form a unique fingerprint.

Medicine & Life Sciences